As filed with the Securities and Exchange Commission on August __, 2001.

                                                Registration No.
                                                                -------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM S-8

                             REGISTRATION STATEMENT
                                      Under
                           The Securities Act of l933


                          L.A.M. PHARMACEUTICAL, CORP.

               (Exact name of issuer as specified in its charter)


                   Delaware                               52-2278236
               ---------------                         ---------------
          (State or other jurisdiction                (I.R.S. Employer
         of incorporation or organization)            Identification No.)

 800 Sheppard Avenue West, Commercial Unit 1,
 Toronto, Ontario, Canada                                   M3H 6B4
- ---------------------------------------------              ---------
(Address of Principal Executive Offices)                   (Zip Code)

                           Incentive Stock Option Plan
                         Non-Qualified Stock Option Plan
                                Stock Bonus Plan
                     ------------------- ------------------
                              (Full Title of Plan)

                                Joseph T. Slechta
                  800 Sheppard Avenue West, Commercial Unit 1,
                             Toronto, Canada M3H 6B4
          -----------------------------------------------------------
                     (Name and address of agent for service)

                        (877) 526-7717 or (416) 633-7047
                        --------------------------------
          (Telephone number, including area code, of agent for service)

Copies of all communications, including all communications sent to agent for
service to:

                              William T. Hart, Esq.
                                  Hart & Trinen
                             l624 Washington Street
                             Denver, Colorado 80203
                                 (303) 839-0061






                         CALCULATION OF REGISTRATION FEE
- --------------------------------------------------------------------------------
                                         Proposed      Proposed
Title of                                 maximum       maximum
Securities                  Amount       offering     aggregate      Amount of
 to be                      to be         price        offering     registration
registered               registered (1) per share (2)   price           fee
- --------------------------------------------------------------------------------

Common Stock Issuable
   Pursuant to Incentive
   Stock Option Plan      1,000,000         $0.67    $   670,000      $  177
Common Stock Issuable
   Pursuant to Non-
   Qualified Stock Option
   Plan                   7,000,000         $0.67     $4,690,000      $1,238
Common Stock Issuable
   Pursuant to Stock Bonus
   Plan                     500,000         $0.67    $   335,000    $     89
                                                     -----------    --------
                                                      $5,695,000      $1,504
                                                     ===========    ========

(1) This Registration Statement also covers such additional number of shares,
    presently undeterminable, as may become issuable under the Plans in the
    event of stock dividends, stock splits, recapitalizations or other changes
    in the common stock. The shares subject to this Registration Statement
    reflect the shares issuable pursuant to the Stock Bonus Plan all of which
    may be reoffered in accordance with the provisions of Form S-8.

(2) Varied, but not less than the fair market value on the date that the options
    were or are granted. Pursuant to Rule 457(g), the proposed maximum offering
    price per share and proposed maximum aggregate offering price are based upon
    the average bid and asked prices of the Registrant's common stock on August
    27, 2001.






                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 3 - Incorporation of Documents by Reference

     The following  documents  filed by L.A.M.  with the Securities and Exchange
Commission are incorporated by reference in this Registration Statement:

(1)  Annual Report on Form 10-KSB for the fiscal year ended December 31, 2000.

(2)  Quarterly report on Form 10-QSB for the quarter ended March 31, 2001.

(3)  Quarterly report on Form 10-QSB for the quarter ended June 30, 2001.

      All reports and documents subsequently filed by L.A.M. pursuant to Section
13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, prior to the
filing of a post-effective amendment to this Registration Statement of which
this Prospectus is a part which indicates that all securities offered hereby
have been sold or which de-registers all securities then remaining unsold, shall
be deemed to be incorporated by reference in this Prospectus and to be a part
thereof from the date of filing of such reports or documents.

Item 4 - Description of Securities

      Not required.

Item 5 - Interests of Named Experts and Counsel

      Not Applicable.

Item 6 - Indemnification of Directors and Officers

      The Delaware General Corporation Law provides in substance that L.A.M.
shall indemnify any person who was or is a party or is threatened to be made a
party to any threatened or completed action, suit or proceeding, whether civil,
criminal, administrative, or investigative by reason of the fact that such
person is or was a director, officer, employee, fiduciary or agent of L.A.M., or
is or was serving at the request of L.A.M. as a director, officer, employee,
fiduciary or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorney's fees), judgements,
fines and amounts paid in settlement actually and reasonably incurred by such
person; and that expenses incurred in defending any such civil or criminal
action, suit or proceeding may be paid by L.A.M. in advance of the final
disposition of such action, suit or proceeding as authorized by the Board of
Directors in the specific case upon receipt of an undertaking by or on behalf of
such director, officer or employee to repay such amount to L.A.M. unless it
shall ultimately be determined that such person is entitled to be indemnified by
L.A.M.




Item 7 - Exemption from Registration Claimed


     On June 5, 2001 L.A.M.  issued 100,000 shares of its common stock to Joseph
T. Slechta, an officer and director of L.A.M., for services rendered.

      The shares issued to Mr. Slechta were not registered under the Securities
Act of 1933 but were sold in reliance upon the exemption provided by Section
4(2) of the Act. The shares of common stock were acquired for investment
purposes only and without a view to distribution. The certificate representing
the shares of common stock bears a legend stating that the shares may not be
offered, sold or transferred other than pursuant to an effective registration
statement under the Securities Act of 1933, or pursuant to an applicable
exemption from registration. The shares are "restricted" securities as defined
in Rule 144 of the Securities and Exchange Commission.

Item 8 - Exhibits
- -----------------

3.1   Certificate of Incorporation as amended                (1)

3.2   Bylaws                                                 (1)
                                                   -------------------------

4.1   Incentive Stock Option Plan
                                                   --------------------------

4.2   Non-Qualified Stock Option Plan
                                                   --------------------------

4.3   Stock Bonus Plan
                                                   -------------------------

5     Opinion of Counsel
                                                   --------------------------

23.1  Consent of Attorneys
                                                   --------------------------

23.2  Consent of Accountants
                                                   --------------------------

24.   Power of Attorney                            Included as part of the
                                                   Signature Page

99 - Additional Exhibits
        (Re-Offer Prospectus)                      --------------------------

(1)  Incorporated by reference to the same exhibit filed with L.A.M.'s
     Registration Statement on Form 10-SB.






Item 9 - Undertakings

      (a)   The undersigned registrant hereby undertakes:

            (1) To file, during any period in which offers or sales are being
      made, a post-effective amendment to this registration statement:

            (i)   to include any prospectus  required by Section  l0(a)(3) of
                  the Securities Act of l933;
            (ii)  to reflect in the prospectus any facts or events arising after
                  the effective date of the registration statement (or the most
                  recent post-effective amendment thereof) which, individually
                  or in the aggregate, represent a fundamental change in the
                  information set forth in the registration statement; and
            (iii) to include any material information with respect to the plan
                  of distribution not previously disclosed in the registration
                  statement or any material change in such information in the
                  registration statement;

            Provided, however, that paragraphs (a)(l)(i) and (a)(l)(ii) will not
apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in periodic reports filed by the registrant
pursuant to Section l3 or Section l5(d) of the Securities Act of l934

            (2) That, for the purpose of determining any liability under the
      Securities Act of l933, each such post-effective amendment shall be deemed
      to be a new registration statement relating to the securities offered
      therein, and the offering of such securities at that time shall be deemed
      to be the initial bona fide offering thereof.

            (3) To remove from registration by means of a post-effective
      amendment any of the securities being registered which remain unsold at
      the termination of the offering.

      (b) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of l933, each filing of the
registrant's Annual Report pursuant to Section l3(a) or Section l5(d) of the
Securities Exchange Act of l934 (and, where applicable, each filing of any
employee benefit plan's annual report pursuant to Section l5(d) of the
Securities Exchange Act of l934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

      (c) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the



registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.







                                POWER OF ATTORNEY

      KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes
and appoints Joseph T. Slechta his true and lawful attorney-in-fact and agent,
with full power of substitution and resubstitution, for him and in his name,
place and stead, in any and all capacities, to sign any and all amendments
(including post-effective amendments) to this Registration Statement, and to
file the same, with all exhibits thereto, and all other documents in connection
therewith, with the Securities and Exchange Commission granting unto said
attorney-in-fact and agent full power and authority to do and perform each and
every act and thing requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorney-in-fact and agent or his substitutes or substitute may
lawfully do or cause to be done by virtue hereof.

                                   SIGNATURES

      Pursuant to the requirements of the Securities Act of l933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Toronto, Ontario, Canada on August 31, 2001.

                                    L.A.M. PHARMACEUTICALS, CORP.

                                    By:    /s/ Joseph T. Slechta
                                          ------------------------------------
                                          Joseph T. Slechta
                                          President, Chief Operating Officer and
                                          Principal Financial Officer

         Pursuant to the requirements of the Securities Act of l933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.

Signature                            Title                    Date

/s/ Joseph T. Slechta
- ---------------------------
Joseph T. Slechta                   Director              August 31, 2001

 /s/ Alan Drizen
Alan Drizen                         Director              August 31, 2001

 /s/ Peter Rothbart
Peter Rothbart                      Director              August 31, 2001

 /s/ Gary M. Nath
- ---------------------------
Gary M. Nath                        Director              August 31, 2001

















                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM S-8
                                    EXHIBITS


                           L.AM. PHARMACEUTICAL, CORP.
                            800 Sheppard Avenue West
                                Commercial Unit 1
                                Toronto, Ontario
                                 Canada M3H 6B4